K4 Elite
K4 Elite
Lab Guides · 2026-08-01
Learning how to read a peptide COA — a Certificate of Analysis, the batch testing document that accompanies a research compound — is the single highest-value technical skill a peptide buyer can pick up. A COA is not marketing collateral. It is a record of what a specific lot of material actually measured on specific instruments, and it either tells you something checkable or it doesn't. This guide walks through the sections in the order they normally appear, explains what each measurement can and cannot establish, and identifies the failure modes that separate a real document from a decorative one.
Two framing points before we start. First, no COA proves a compound is safe or effective — it characterizes chemistry, nothing more. Second, and less obvious: the sections do different jobs, and a strong result in one cannot compensate for a missing result in another. A 99% purity figure means very little if nothing on the page establishes what the 99% is.
HPLC (high-performance liquid chromatography — a technique that pushes a dissolved sample through a packed column so its components separate by how strongly they stick to the packing) is the standard purity method for peptides, usually in its reversed-phase form, RP-HPLC. Components exit the column at different times and pass a UV detector, producing a chromatogram: a trace with time on the x-axis and detector response on the y-axis.
Each peak is a species that eluted at a distinct time. The purity percentage is calculated by area normalization: the area under the main peak divided by the total area of all peaks, expressed as a percentage. Bachem, one of the oldest contract peptide manufacturers, describes exactly this convention — purity assessed by UV detection at 210–220 nm, main-peak area over total area [1].
That detection wavelength matters more than it looks. The peptide bond itself absorbs strongly around 210–220 nm, which is why the method is close to universal for peptides regardless of sequence. But it also means the number is a relative figure among UV-absorbing species. Anything in the vial that doesn't absorb at that wavelength — water, most salts, counterions — is invisible to it and is not counted as an impurity. This is the root of the most common misreading of a COA, and we return to it in Section 3.
What to look for on the chromatogram image itself:
HPLC tells you how much of one thing there is. It does not tell you what that thing is. Mass spectrometry (MS — a technique that ionizes molecules and sorts them by mass-to-charge ratio) answers the identity question by measuring molecular weight, which is then compared against the value calculated from the intended sequence [1].
On the COA you should find two numbers side by side:
These should agree closely. Small discrepancies are usually explainable: electrospray ionization commonly produces multiply charged ions, so a spectrum may show m/z values at [M+H]⁺, [M+2H]²⁺ and so on rather than the intact mass directly. Average versus monoisotopic mass conventions also differ by a fraction of a percent on larger peptides. A gap of several mass units, however, is not a rounding artifact — a shift of about +16 is the classic signature of an added oxygen (oxidation), and −17 or −18 suggests loss of ammonia or water.
The practical rule: identity and purity must both be present. A COA with a purity assay and no mass confirmation has verified that a batch contains mostly one compound, without establishing which compound.
This is where most readers of a COA go wrong, and it is worth slowing down for. When a vial is labelled 5 mg, that figure is normally the gross weight of the lyophilized (freeze-dried) powder placed in the vial. That powder is not pure peptide by mass.
Peptides purified by RP-HPLC are typically isolated as salts. Basic residues (arginine, lysine, histidine) and the free N-terminus are protonated and carry a counterion — most often trifluoroacetate (TFA) from the purification mobile phase, sometimes acetate or chloride. Bachem notes that these counterions are firmly bound as the salt and, in the TFA case, cannot be fully removed without a separate ion-exchange step [1]. Lyophilized peptides also retain residual water, and many are hygroscopic (they pull moisture from the air).
Net peptide content (NPC) is the percentage of the material that is actually peptide, as opposed to counterions and moisture. It is measured separately from purity — by quantitative amino acid analysis or by nitrogen determination from elemental analysis [1]. Critically, NPC and purity are not the same measurement and are not interchangeable:
| Metric | Question it answers | Typical method |
| HPLC purity | Of the peptide-like material present, what fraction is the target? | RP-HPLC, UV 210–220 nm, area % |
| Net peptide content | Of the total powder mass, what fraction is peptide at all? | Amino acid analysis or nitrogen/elemental analysis |
The consequence is that a batch can be both 98% pure and meaningfully below 100% peptide by weight — those statements are entirely compatible. Bachem explicitly warns that a low NPC should be expected for peptides rich in basic residues, even when the material is extremely pure, purely because of salt formation, and that both figures must be taken into account when preparing solutions for assays [1]. If you are calculating a working concentration and you use gross vial weight while ignoring NPC, your stated concentration is systematically too high. For sequences with several arginines or lysines, that error is not trivial.
Two smaller sections that fill out the mass balance. Water content is determined by Karl Fischer titration, a chemical assay specific to water [1]. It matters twice over: water is part of the non-peptide mass that reduces NPC, and residual moisture in a freeze-dried solid is a well-established driver of degradation during storage [2].
Residual solvents — traces of the organic solvents used in synthesis and purification — are determined by gas chromatography [1]. Limits for solvents in pharmaceutical materials are set out in ICH Q3C, adopted by FDA as guidance for industry [3]. Research-grade material is not held to pharmaceutical release standards, but the presence of the test at all indicates a manufacturer working to a recognized framework rather than an ad-hoc one.
Endotoxins are lipopolysaccharides from the outer membrane of Gram-negative bacteria. They survive processes that kill the bacteria themselves, which is why sterility and endotoxin are separate questions. The standard screen is the LAL test (Limulus Amebocyte Lysate — an extract of horseshoe crab blood cells that reacts measurably with endotoxin), performed under USP General Chapter <85>, the Bacterial Endotoxins Test. FDA's guidance on pyrogen and endotoxins testing describes the accepted methods — gel-clot, turbidimetric and chromogenic — and the gel-clot limit test's role as the referee method in disputes [4][5].
In a laboratory context, the reason to care is contamination control, not safety: endotoxin is a potent activator of innate immune signalling in cell culture at very low concentrations, and an unscreened reagent can quietly confound any inflammatory or immune readout. An endotoxin result on a COA is a research-quality signal, not a clearance for any other use.
When you receive a COA, work the checklist in this order: lot number matches the vial → date present → method stated → chromatogram legible → observed mass matches theoretical → net peptide content reported → then, and only then, look at the purity percentage. Reading the headline number first is how people talk themselves into ignoring the four things that would have told them the number was meaningless.
K4 Elite completes a Certificate of Analysis for every batch, and COAs for current lots can be requested from our COA page. If you are evaluating a specific compound — for example BPC-157, TB-500 or Tirzepatide — request the COA for the current lot and run the checklist above against it before you plan an experiment around the material. For the related question of what happens to a peptide after the COA is written, see our companion guides on bacteriostatic water and reconstitution and on the preclinical literature behind BPC-157 in tissue-repair research.
A COA is a chain of custody for a number. HPLC establishes how much of one species is present, mass spectrometry establishes which species it is, net peptide content establishes how much of the powder is peptide at all, and water, solvent and endotoxin testing close the remaining gaps. Any of these can be strong while the others are absent — which is precisely why the document, not the headline percentage, is the thing to read.
All compounds discussed are supplied strictly for in-vitro and laboratory research use only. Nothing above is medical advice, dosing guidance, or a claim of safety or efficacy in humans. Analytical testing characterizes chemical identity and composition; it does not establish suitability for any human or veterinary application. Purchasers are responsible for compliance with all applicable laws.